BackApogee Therapeutics Overview

Apogee Therapeutics Other Current Liabilities

Apogee Therapeutics's other current liabilities is $29M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$28.58M
18.61% YoYΔ $4.48M vs prior year quarter

Peer average / median

Loading

Apogee Therapeutics Other Current Liabilities History

Loading

Apogee Therapeutics vs. peers: Other Current Liabilities Comparison

Loading

Apogee Therapeutics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Apogee Therapeutics (APGE) FAQ

As of the most recent data (March 2026), APGE shows a other current liabilities of $29M. That compares with $24M in the prior-year period — up 18.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APGE's other current liabilities is now $29M (was $24M) — a 18.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apogee Therapeutics is outperforming or lagging.

Tracking APGE's other current liabilities over time shows whether Apogee Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $29M That compares with $24M in the prior-year period — up 18.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Apogee Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $29M) with ownership activity and broader fundamentals.